Effects of exposure to acrolein vapor in hamsters simultaneously treated with benzo[a]pyrene or diethylnitrosamine
- 20 October 1977
- journal article
- research article
- Published by Taylor & Francis in Journal of Toxicology and Environmental Health
- Vol. 3 (3) , 379-394
- https://doi.org/10.1080/15287397709529571
Abstract
The biological effects of repeated exposures to acrolein (CH2 = CHCHO) vapor combined with either intratracheal instillation of benzo[a]pyrene (BP) or s.c. injection of diethylnitrosamine (DENA) were examined in an 81 wk study with Syrian golden hamsters. The hamsters, 252 males and 252 females, were evenly distributed over 2 inhalation chambers, 1 chamber for air exposure and the other for exposure to 4.0 ppm (9.2 mg/m3) acrolein, 7 h/day, 5 days/wk, for a period of 52 wk. Equal numbers of animals in each chamber were treated with BP, DENA or 0.9% NaCl solution. Observations were made of general appearance, body weight, mortality, hematological and biochemical factors, organ weights, and gross and microscopic pathology. At the end of the treatment period (wk 52) 6 animals of each sex per chamber not treated with BP or DENA were killed and extensively examined. The remaining hamsters were killed after 81 wk and examined only for changes in the respiratory tract. Exposure to acrolein resulted in abnormal behavior; growth retardation; increases in hb content, packed cell volume and relative lung weight; decreased relative liver weight; and rhinitis accompanied by hyper- and metaplasia of the epithelium in the nasal cavity. There was no indication of a carcinogenic activity of acrolein. Respiratory tract tumors were found in males and females treated with BP or DENA. The types of tumors found were those usually seen in hamster following administration of these carcinogens. Indications of an enhancing effect of acrolein on BP carcinogenesis were doubtful. The carcinogenic effect of DENA on the respiratory tract appeared not to be influenced by exposure to acrolein vapor. The study probably produced insufficient evidence to enable acrolein to be regarded as an evident cofactor in respiratory tract carcinogenesis.This publication has 12 references indexed in Scilit:
- Functional and biochemical effects on the lung following inhalation of cigarette smoke and constituents. II. Skatole, acrolein, and acetaldehydeToxicology and Applied Pharmacology, 1974
- Subcellular reactions of acrolein: Munsch, Nicole, de Recondo, Anne-Marie & Frayssinet, C. (1973). Effects of acrolein on DNA synthesis in vitro. FEBS Lett.30, 286 Zollner, H. (1973). Inhibition of some mitochondrial functions by acrolein and methylvinylketone. Biochem. Pharmac.22, 1171Food and Cosmetics Toxicology, 1974
- Dose-dependent sympathomimetic and cardioinhibitory effects of acrolein and formaldehyde in the anesthetized ratToxicology and Applied Pharmacology, 1974
- Effects of acrolein on DNA synthesis in vitroFEBS Letters, 1973
- An evaluation of the criterion “Organ weight” under conditions of growth retardationFood and Cosmetics Toxicology, 1973
- Repeated and continuous exposure of laboratory animals to acroleinToxicology and Applied Pharmacology, 1970
- The mechanism of carcinogenesis by tobacco smoke. Further experimental evidence and a prediction from the thiol-defence hypothesisBritish Journal of Cancer, 1968
- The mechanism of carcinogenesis by tobacco smoke. Some experimental observations and a hypothesis.British Journal of Cancer, 1967
- Mechanism of the effect of acrolein on rat liver enzymesToxicology and Applied Pharmacology, 1965
- Components of Cigarette Smoke with Ciliary-Depressant ActivityNew England Journal of Medicine, 1963